Which social media platforms facilitate monitoring the opioid crisis?

Kristy A. Carpenter; Anna T. Nguyen; Delaney A. Smith; Issah A. Samori; Keith Humphreys; Anna Lembke; Mathew V. Kiang; Johannes C. Eichstaedt; Russ B. Altman

doi:10.1101/2024.07.06.24310035

Abstract

Social media can provide real-time insight into trends in substance use, addiction, and recovery. Prior studies have used platforms such as Reddit and X (formerly Twitter), but evolving policies around data access have threatened these platforms’ usability in research. We evaluate the potential of a broad set of platforms to detect emerging trends in the opioid epidemic. From these, we created a shortlist of 11 platforms, for which we documented official policies regulating drug-related discussion, data accessibility, geolocatability, and prior use in opioid-related studies. We quantified their volumes of opioid discussion, capturing informal language by including slang generated using a large language model. Beyond the most commonly used Reddit and X, the platforms with high potential for use in opioid-related surveillance are TikTok, YouTube, and Facebook. Leveraging many different social platforms, instead of a single platform, safeguards against sudden changes to data access and may better capture all populations that use opioids than any single platform.

Teaser TikTok, Facebook, and YouTube may complement Reddit and X as text sources to monitor trends in the opioid epidemic.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work supported by: NIH DA057598; Microsoft Accelerating Foundation Models Research Initiative; NSF GRFP DGE-1656518 to KAC; NIH NHLBI T32HL151323 to ATN; DAS is supported by the Stanford Biochemistry Department and NSF GRFP 2019286895; Stanford Summer First Fellowship to IAS; Sarafan ChEM-H CBI Program Award to IAS; KH is supported by a Senior Research Career Scientist Award (RCS 04-141-3) from the Department of Veterans Affairs Health System Research Service; JCE, RBA, AL are supported by the Stanford Institute for Human-Centered AI; RBA is supported by the Chan Zuckerberg Biohub.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Public social media posts indexed by Google

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes